These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34100216)

  • 1. Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells.
    Smiley SB; Yun Y; Ayyagari P; Shannon HE; Pollok KE; Vannier MW; Das SK; Veronesi MC
    Pharm Res; 2021 Jun; 38(6):1067-1079. PubMed ID: 34100216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.
    Kim JS; Shin DH; Kim JS
    J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood-brain-barrier and glioblastoma stem cells.
    Zhao C; Zhu X; Yang H; Tan J; Gong R; Mei C; Cai X; Su Z; Kong F
    Biomed Mater; 2024 Aug; 19(5):. PubMed ID: 39134023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-
    Banstola A; Duwa R; Emami F; Jeong JH; Yook S
    Mol Pharm; 2020 Nov; 17(11):4386-4400. PubMed ID: 33079558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
    Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
    Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
    Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A
    Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
    Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
    Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.
    Liu YC; Lee IC; Chen PY
    J Neurooncol; 2018 May; 137(3):511-522. PubMed ID: 29357090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
    Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
    Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.
    William D; Walther M; Schneider B; Linnebacher M; Classen CF
    PLoS One; 2018; 13(1):e0191511. PubMed ID: 29352318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines.
    Beier D; Schriefer B; Brawanski K; Hau P; Weis J; Schulz JB; Beier CP
    J Neurooncol; 2012 Aug; 109(1):45-52. PubMed ID: 22544650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amrubicin encapsulated PLGA NPs inhibits the PI3K/AKT signaling pathway by activating PTEN and inducing apoptosis in TMZ-resistant Glioma.
    Younis M; Shaikh S; Shahzad KA; Tan F; Wang Z; Lashari MH
    Biomed Mater; 2024 Jan; 19(2):. PubMed ID: 38181444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
    Wang H; Cai S; Bailey BJ; Reza Saadatzadeh M; Ding J; Tonsing-Carter E; Georgiadis TM; Zachary Gunter T; Long EC; Minto RE; Gordon KR; Sen SE; Cai W; Eitel JA; Waning DL; Bringman LR; Wells CD; Murray ME; Sarkaria JN; Gelbert LM; Jones DR; Cohen-Gadol AA; Mayo LD; Shannon HE; Pollok KE
    J Neurosurg; 2017 Feb; 126(2):446-459. PubMed ID: 27177180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a novel imaging agent using peptide-coated gold nanoparticles toward brain glioma stem cell marker CD133.
    Cho JH; Kim AR; Kim SH; Lee SJ; Chung H; Yoon MY
    Acta Biomater; 2017 Jan; 47():182-192. PubMed ID: 27721007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
    Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
    J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
    Fadera S; Chen PY; Liu HL; Lee IC
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy.
    Kadhim ZA; Sulaiman GM; Al-Shammari AM; Khan RA; Al Rugaie O; Mohammed HA
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.